iFuse Implant System® Minimally Invasive Arthrodesis (iMIA)
A Multicenter Randomized Controlled Post-market Clinical Follow-up Trial Comparing the Effectiveness and Safety of the iFuse Implant System® Versus Conservative Management for Patients With Chronic, Disabling SI Joint Pain.
Sponsor: SI-BONE, Inc.
Listed as NCT01741025, this NA trial focuses on Sacroiliac Joint Pain and remains completed. Sponsored by SI-BONE, Inc., it has been updated 6 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 1 earlier version
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- SI-BONE, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .